Kathleen Sebelius - Net Worth and Insider Trading
Kathleen Sebelius Net Worth
The estimated net worth of Kathleen Sebelius is at least $355,770 dollars as of 2024-11-13. Kathleen Sebelius is the Director of Humacyte Inc and owns about 41,207 shares of Humacyte Inc (HUMA) stock worth over $220,870. Kathleen Sebelius is also the Director of Myovant Sciences Ltd and owns about 5,000 shares of Myovant Sciences Ltd (MYOV) stock worth over $134,900. Details can be seen in Kathleen Sebelius's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kathleen Sebelius has not made any transactions after 2024-09-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kathleen Sebelius
Kathleen Sebelius Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kathleen Sebelius owns 4 companies in total, including Myovant Sciences Ltd (MYOV) , Exact Sciences Corp (EXAS) , and Dermira Inc (DERM) among others .
Click here to see the complete history of Kathleen Sebelius’s form 4 insider trades.
Insider Ownership Summary of Kathleen Sebelius
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MYOV | Myovant Sciences Ltd | 2019-06-12 | director |
| EXAS | Exact Sciences Corp | 2019-03-03 | director |
| DERM | Dermira Inc | 2020-02-20 | director |
 | | 2024-09-10 | director |
Kathleen Sebelius Latest Holdings Summary
Kathleen Sebelius currently owns a total of 2 stocks. Among these stocks, Kathleen Sebelius owns 41,207 shares of Humacyte Inc (HUMA) as of September 10, 2024, with a value of $220,870 and a weighting of 62.08%. Kathleen Sebelius also owns 5,000 shares of Myovant Sciences Ltd (MYOV) as of June 12, 2019, with a value of $134,900 and a weighting of 37.92%.
Latest Holdings of Kathleen Sebelius
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HUMA | Humacyte Inc | 2024-09-10 | 41,207 | 5.36 | 220,870 |
| MYOV | Myovant Sciences Ltd | 2019-06-12 | 5,000 | 26.98 | 134,900 |
Holding Weightings of Kathleen Sebelius
Kathleen Sebelius Form 4 Trading Tracker
According to the SEC Form 4 filings, Kathleen Sebelius has made a total of 1 transactions in Humacyte Inc (HUMA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Humacyte Inc is the sale of 5,182 shares on September 10, 2024, which brought Kathleen Sebelius around $27,983.
According to the SEC Form 4 filings, Kathleen Sebelius has made a total of 0 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years. The most-recent trade in Myovant Sciences Ltd is the acquisition of 5,000 shares on June 12, 2019, which cost Kathleen Sebelius around $44,800.
Insider Trading History of Kathleen Sebelius
- 1
Kathleen Sebelius Trading Performance
GuruFocus tracks the stock performance after each of Kathleen Sebelius's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kathleen Sebelius is -27.29%. GuruFocus also compares Kathleen Sebelius's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kathleen Sebelius within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kathleen Sebelius's insider trading performs compared to the benchmark.
Performance of Kathleen Sebelius
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.91 | | | | | |
| Relative Return to S&P 500(%) | -8.56 | | | | | |
Kathleen Sebelius Ownership Network
Ownership Network List of Kathleen Sebelius
Ownership Network Relation of Kathleen Sebelius
Kathleen Sebelius Owned Company Details
What does Myovant Sciences Ltd do?
Who are the key executives at Myovant Sciences Ltd?
Kathleen Sebelius is the director of Myovant Sciences Ltd. Other key executives at Myovant Sciences Ltd include 10 percent owner Sumitomo Chemical Co., Ltd. , Chief Commercial Officer Lauren Merendino , and General Counsel & Corp. Secy. Matthew Lang .
Myovant Sciences Ltd (MYOV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Myovant Sciences Ltd (MYOV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Myovant Sciences Ltd (MYOV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Myovant Sciences Ltd (MYOV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Myovant Sciences Ltd Insider Transactions
Kathleen Sebelius Mailing Address
Above is the net worth, insider trading, and ownership report for Kathleen Sebelius. You might contact Kathleen Sebelius via mailing address: C/o Dermira, Inc., 275 Middlefield Road, Suite 150, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
